Detens

Detens may be available in the countries listed below.

Ingredient matches for Detens

Clobazam

Clobazam is reported as an ingredient of Detens in the following countries:

• Bangladesh

International Drug Name Search

Nevipan

Nevipan may be available in the countries listed below.

Ingredient matches for Nevipan

Nevirapine

Nevirapine is reported as an ingredient of Nevipan in the following countries:

• Ethiopia


• Myanmar

International Drug Name Search

Docbudeso

Docbudeso may be available in the countries listed below.

Ingredient matches for Docbudeso

Budesonide

Budesonide is reported as an ingredient of Docbudeso in the following countries:

• Belgium


• Luxembourg

International Drug Name Search

Diastat AcuDial

See also: Generic Diastat

Diastat AcuDial is a brand name of diazepam, approved by the FDA in the following formulation(s):

DIASTAT ACUDIAL (diazepam - gel; rectal)

• 
  Manufacturer: VALEANT
  
  Approval date: September 15, 2005
  
  Strength(s): 10MG/2ML (5MG/ML), 20MG/4ML (5MG/ML) ^[RLD]

Has a generic version of Diastat AcuDial been approved?

No. There is currently no therapeutically equivalent version of Diastat AcuDial available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Diastat AcuDial. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Rectally-administered, epileptic-seizure-inhibiting composition
  Patent 5,462,740
  Issued: October 31, 1995
  Inventor(s): Evenstad; Kenneth L. & O'Neill; Victoria A. & Gorham; Thomas R.
  Assignee(s): Athena Neurosciences, Inc.
  This invention provides a rectally administered composition for inhibiting epileptic seizure and to its methods of use. The composition contains, in a suitable solvent, an anti-epileptic agent for inhibiting epileptic seizure, a buffer for maintaining pH, and a thickener for imparting a viscosity to the composition effective for rectal administration by injection to a patient in epileptic seizure.
  
  Patent expiration dates:
  
  
  • September 17, 2013
    
    ✓ 
    Drug product
  
  

See also...

• Diastat AcuDial Gel Consumer Information (Wolters Kluwer)
• Diastat AcuDial Consumer Information (Cerner Multum)
• Diazepam Consumer Information (Drugs.com)
• Diazepam Consumer Information (Wolters Kluwer)
• Diazepam Concentrate Consumer Information (Wolters Kluwer)
• Diazepam Gel Consumer Information (Wolters Kluwer)
• Diazepam Solution Consumer Information (Wolters Kluwer)
• Diazepam Tablets Consumer Information (Wolters Kluwer)
• Diazepam Consumer Information (Cerner Multum)
• Diazepam rectal Consumer Information (Cerner Multum)
• Diazepam Advanced Consumer Information (Micromedex)
• Diazepam Injection Advanced Consumer Information (Micromedex)
• Diazepam Rectal Advanced Consumer Information (Micromedex)
• Diazepam AHFS DI Monographs (ASHP)

Mobic

In the US, Mobic (meloxicam systemic) is a member of the drug class nonsteroidal anti-inflammatory agents and is used to treat Fibromyalgia, Inflammatory Conditions, Juvenile Rheumatoid Arthritis, Osteoarthritis, Rheumatoid Arthritis and Tendonitis.

US matches:

• Mobic


• Mobic Suspension

UK matches:

• Mobic Suppositories 15mg
• Mobic Suppositories 7.5mg
• Mobic Tablets 15mg
• Mobic Tablets 7.5mg
• Mobic 15mg Suppositories (SPC)
• Mobic 15mg Tablets (SPC)
• Mobic 7.5mg Suppositories (SPC)
• Mobic 7.5mg Tablets (SPC)

Ingredient matches for Mobic

Meloxicam

Meloxicam is reported as an ingredient of Mobic in the following countries:

• Argentina


• Australia


• Bahrain


• Belgium


• Colombia


• Cyprus


• Egypt


• Finland


• France


• Guyana


• Hong Kong


• Iraq


• Ireland


• Italy


• Japan


• Jordan


• Kenya


• Kuwait


• Lebanon


• Libya


• Luxembourg


• Malaysia


• Malta


• New Zealand


• Norway


• Oman


• Peru


• Qatar


• Saudi Arabia


• Singapore


• South Africa


• Sudan


• Taiwan


• Thailand


• Tunisia


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Vietnam


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dolgic LQ Elixir

Pronunciation: ah-seet-ah-MIN-oh-fen/byoo-TAL-bi-tal/kaf-EEN
Generic Name: Acetaminophen/Butalbital/Caffeine
Brand Name: Examples include Alagesic LQ and Dolgic LQ

Dolgic LQ Elixir contains acetaminophen. Severe and sometimes fatal liver problems, including the need for liver transplant, have been reported with the use of acetaminophen. Most cases of these liver problems occurred in patients taking excessive doses of acetaminophen (more than 4,000 mg per day). Also, patients who developed these liver problems were often using more than 1 medicine that contained acetaminophen. Discuss any questions or concerns with your doctor.

Dolgic LQ Elixir is used for:

Relieving tension headaches. It may also be used for other conditions as determined by your doctor.

How these medicines work is not completely understood. Acetaminophen works in the brain to relieve pain. Caffeine may work by constricting blood vessels that may cause headaches. Butalbital has a depressant effect that reduces anxiety and causes relaxation.

Do NOT use Dolgic LQ Elixir if:

• you are allergic to any ingredient in Dolgic LQ Elixir


• you have the blood disease porphyria


• you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dolgic LQ Elixir:

Some medical conditions may interact with Dolgic LQ Elixir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have liver problems, severe kidney problems, severe heart disease, a lung or respiratory tract disease, or difficulty sleeping


• if you have a history of substance abuse or dependence, anxiety, depression, or suicidal thoughts or behaviors

Some MEDICINES MAY INTERACT with Dolgic LQ Elixir. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Benzodiazepines (eg, chlordiazepoxide), monoamine oxidase inhibitors (MAOIs) (eg, phenelzine), narcotic analgesics (eg, morphine), sleeping medicines (eg, temazepam), or sodium oxybate (GHB) because they may increase the risk of Dolgic LQ Elixir's side effects


• Anticoagulants (eg, warfarin) or isoniazid because the risk of side effects, including bleeding and liver problems, may be increased


• Beta-blockers (eg, atenolol), clozapine, corticosteroids (eg, prednisone), doxycycline, estrogens (eg, estradiol, oral contraceptives), metronidazole, quinidine, quinolone antibiotics (eg, ciprofloxacin), or theophylline, because their effectiveness may be decreased by Dolgic LQ Elixir

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dolgic LQ Elixir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dolgic LQ Elixir:

Use Dolgic LQ Elixir as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Dolgic LQ Elixir by mouth with or without food.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Dolgic LQ Elixir and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is almost time for your next dose, do not double the dose to catch up, unless advised to do so by your doctor. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dolgic LQ Elixir.

Important safety information:

• Dolgic LQ Elixir may cause drowsiness. This effect may be worse if you take it with alcohol or certain medicines. Use Dolgic LQ Elixir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Dolgic LQ Elixir; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Pain medications work best if they are used as the first signs of pain (or migraine) occur. If you wait until the pain has significantly worsened, the pain medicine may not work as well.


• Dolgic LQ Elixir has acetaminophen in it. Before you start any new medicine, check the label to see if it has acetaminophen in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Dolgic LQ Elixir may harm your liver. Your risk may be greater if you drink alcohol while you are using Dolgic LQ Elixir. Talk to your doctor before you take Dolgic LQ Elixir or other pain relievers/fever reducers if you drink more than 3 drinks with alcohol per day.


• Tell your doctor or dentist that you take Dolgic LQ Elixir before you receive any medical or dental care, emergency care, or surgery.


• Hormonal birth control (eg, birth control pills) may not work as well while you are using Dolgic LQ Elixir. To prevent pregnancy, use an extra form of birth control (eg, condoms).


• Lab tests, including liver and kidney function, may be performed while you use Dolgic LQ Elixir. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Dolgic LQ Elixir with caution in the ELDERLY; they may be more sensitive to its effects.


• Dolgic LQ Elixir should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dolgic LQ Elixir while you are pregnant. Dolgic LQ Elixir is found in breast milk. Do not breast-feed while taking Dolgic LQ Elixir.

When used for long periods of time or at high doses, Dolgic LQ Elixir may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Dolgic LQ Elixir stops working well. Do not take more than prescribed.

Some people who use Dolgic LQ Elixir for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. If you stop taking Dolgic LQ Elixir suddenly, you may have WITHDRAWAL symptoms. These may include anxiety, muscle twitching, trembling hands and fingers, weakness, dizziness, hallucinations, nausea, vomiting, sleeplessness, lightheadedness, or seizures.

Possible side effects of Dolgic LQ Elixir:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; drowsiness; intoxicated feeling; lightheadedness; nausea.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; seizures; severe drowsiness; shortness of breath; slurred speech; stomach pain; weakness.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dolgic LQ side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include cold or clammy skin; confusion; dark urine; excessive sweating; extremely fast heartbeat; fatigue; lack of alertness; lightheadedness; loss of consciousness; nausea; sleeplessness; slow or shallow breathing; stomach pain; tremor; unusual drowsiness or dizziness; vomiting.

Proper storage of Dolgic LQ Elixir:

Store Dolgic LQ Elixir at room temperature between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dolgic LQ Elixir out of the reach of children and away from pets.

General information:

• If you have any questions about Dolgic LQ Elixir, please talk with your doctor, pharmacist, or other health care provider.


• Dolgic LQ Elixir is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dolgic LQ Elixir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dolgic LQ resources

• Dolgic LQ Side Effects (in more detail)
• Dolgic LQ Use in Pregnancy & Breastfeeding
• Dolgic LQ Drug Interactions
• Dolgic LQ Support Group
• 0 Reviews for Dolgic LQ - Add your own review/rating

Compare Dolgic LQ with other medications

• Headache

Griseofort

Griseofort may be available in the countries listed below.

Ingredient matches for Griseofort

Griseofulvin

Griseofulvin is reported as an ingredient of Griseofort in the following countries:

• Indonesia

International Drug Name Search

Metotressato Teva

Metotressato Teva may be available in the countries listed below.

Ingredient matches for Metotressato Teva

Methotrexate

Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Metotressato Teva in the following countries:

• Italy

International Drug Name Search